633-03-4
CAS 633-03-4
633-03-4 (CAS 633-03-4) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 37.858909090909094 nM | 55 | - |
| - | Potency | 10407.125 nM | 42 | - |
| - | IC50 | 28356.05416666667 nM | 12 | - |
| - | Potency | 21680.4 nM | 10 | - |
| - | AC50 | 896.25 nM | 4 | - |
| - | IC50 | 1282 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 633-03-4 used for in pharmaceutical contexts?
633-03-4 (CAS 633-03-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 633-03-4?
No adverse-event association or SIDER side-effect rows are rendered for 633-03-4 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 633-03-4 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Basic Green 1 with EU status "prohibited".
What clinical phase is 633-03-4 in?
No phase 1-4 clinical development badge is rendered for 633-03-4 because the matched compound identifier rows do not contain a max-phase value.